SPK Acquisition (SPK) Short Interest Ratio & Short Volume

Short interest is the volume of SPK Acquisition shares that have been sold short but have not yet been covered or closed out. As of December 15th, traders have sold 2,400 shares of SPK short. 10.30% of SPK Acquisition's shares are currently sold short. Learn More on SPK Acquisition's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.30% of SPK Acquisition's floating shares are currently sold short.

SPK Acquisition saw a decrease in short interest in December. As of December 15th, there was short interest totaling 2,400 shares, a decrease of 35.1% from the previous total of 3,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

SPK Acquisition currently has issued a total of 6,596,000 shares. Some of SPK Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. SPK Acquisition currently has a public float of 23,300 shares.

10.30% of SPK Acquisition's shares are currently sold short. Here is how the short interest of companies compare to SPK Acquisition: Entera Bio Ltd. (0.31%), Passage Bio, Inc. (3.57%), Instil Bio, Inc. (0.22%), Semper Paratus Acquisition Co. (0.25%), Elutia Inc. (0.14%), Ikena Oncology, Inc. (4.97%), Genenta Science S.p.A. (0.02%), Aligos Therapeutics, Inc. (1.15%), Cognition Therapeutics, Inc. (0.53%), AVROBIO, Inc. (0.37%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.47 billion), Suncor Energy Inc. ($2.33 billion), T. Rowe Price Group, Inc. ($2.14 billion), PG&E Co. ($1.61 billion), Etsy, Inc. ($1.56 billion), Paramount Global ($1.53 billion), Old Dominion Freight Line, Inc. ($1.49 billion), Coinbase Global, Inc. ($1.46 billion), DICK'S Sporting Goods, Inc. ($1.30 billion), and C.H. Robinson Worldwide, Inc. ($1.26 billion). View all of the most shorted stocks.

Short selling SPK is an investing strategy that aims to generate trading profit from SPK Acquisition as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for SPK Acquisition occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPK, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPK, twice per month. The most recent reporting period available is December, 15 2022.